Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Gains from Investment Securities (2018 - 2025)

Historic Gains from Investment Securities for Evolus (EOLS) over the last 8 years, with Q3 2025 value amounting to -$107000.0.

  • Evolus' Gains from Investment Securities fell 10440.69% to -$107000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$305000.0, marking a year-over-year decrease of 10606.48%. This contributed to the annual value of $7.2 million for FY2024, which is 5771.43% up from last year.
  • Evolus' Gains from Investment Securities amounted to -$107000.0 in Q3 2025, which was down 10440.69% from -$3.9 million recorded in Q2 2025.
  • Evolus' 5-year Gains from Investment Securities high stood at $2.4 million for Q3 2024, and its period low was -$3.9 million during Q2 2025.
  • Its 5-year average for Gains from Investment Securities is $1.2 million, with a median of $1.6 million in 2024.
  • As far as peak fluctuations go, Evolus' Gains from Investment Securities surged by 36890.03% in 2024, and later plummeted by 34386.29% in 2025.
  • Quarter analysis of 5 years shows Evolus' Gains from Investment Securities stood at $2.2 million in 2021, then fell by 19.28% to $1.8 million in 2022, then crashed by 132.17% to -$582000.0 in 2023, then soared by 368.9% to $1.6 million in 2024, then plummeted by 106.84% to -$107000.0 in 2025.
  • Its Gains from Investment Securities was -$107000.0 in Q3 2025, compared to -$3.9 million in Q2 2025 and $2.2 million in Q1 2025.